A recent study conducted by Dr. med. Michael Winkelmann and his colleagues at the LMU Klinikum München explored the association between TGR dynamics from pre-treatment to post-treatment imaging and the patients' outcomes.
The research provides valuable insights into the potential of TGR as a novel prognostic imaging biomarker in the context of CAR-T therapy for patients with relapsed or refractory non-Hodgkin's lymphoma.
Study with mint Lesion™ Uncovers the Impact of Tumor Growth Rate in Predicting the Efficacy of CAR-T-cell Therapy in Lymphoma Patients
Related Resources
Related Resources
Rare Tumors, Big Goals: How RACOON-SAGA Aims to Improve Therapy Decisions
Rare tumors, major challenges: The RACOON-SAGA project explores how imaging and clinical data can improve the pre-therapeutic characterization of soft…
Structured Reporting and Artificial Intelligence in Prostate Diagnostics: An Interview with Prof. Dr. Thorsten Persigehl
What does radiology look like when structured reporting meets artificial intelligence? A look into the daily practice of Prof. Dr. Thorsten Persigehl…
RACOON SAGA: Interdisciplinary Research for Better Therapy Decisions in Sarcoma Treatment
Sarcomas are rare tumors that pose particular challenges to both medicine and research. Their heterogeneity makes precise diagnostics difficult, which…